During the past decade, NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 13 clinical trials were completed, i.e. on average, 48.1% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 12 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill" #1 sponsor was "Gilead Sciences" with 8 trials, followed by "University of North Carolina, Chapel Hill" with 7 trials sponsored, "Aimmune Therapeutics, Inc." with 5 trials sponsored, "Pfizer" with 5 trials sponsored and "Vertex Pharmaceuticals Incorporated" with 5 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill" #1 collaborator was "ICON plc" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator, "PPD" with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill" are "Peanut Allergy" (5 trials), "Cystic Fibrosis" (3 trials), "HIV-1 Infection" (3 trials), "Alopecia Areata" (2 trials) and "Nonalcoholic Steatohepatitis" (2 trials). Many other conditions were trialed in "NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill" in a lesser frequency.

Most popular intervention types in "NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill" are "Drug" (25 trials), "Biological" (8 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "AR101" (4 trials), "B/F/TAF" (2 trials), "ELX/TEZ/IVA" (2 trials) and "IVA" (2 trials). Other intervention names were less common.

The vast majority of trials in "NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill" are 31 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 19 completed trials in NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill, 4 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".